| Dystrophin is a possible end-target of ischemic preconditioning against cardiomyocyte oncosis during the early phase of reperfusion. | |
| | |
MedLine Citation:
|
PMID: 16466703 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Dystrophin is a sarcolemmal membrane protein that prevents the myocyte from oncosis induced by physical stress. Because ischemic preconditioning (IPC) protects mitochondria and prevents oncosis during reperfusion, we hypothesized that dystrophin is an end-target of IPC distal to mitochondrial protection. METHODS AND RESULTS: Isolated rat hearts were subjected to 30 min ischemia followed by reperfusion. IPC was introduced by 3 cycles of 5 min ischemia and 5 min reperfusion. The loss of sarcolemmal dystrophin and myocardial ATP during ischemia was comparable between the control and the IPC heart. Similar changes in sarcolemmal dystrophin and myocardial ATP were observed when the heart was treated with 2,4-dinitrophenol (DNP), an uncoupler of mitochondrial respiration, or oligomycin, an inhibitor of mitochondrial F1F0-ATPase. However, the IPC heart increased sarcolemmal dystrophin during reperfusion associated with an increase in tetramethylrhodamine ethylester (TMRE) uptake, an indicator of mitochondrial membrane potential (DeltaPsim), and myocardial ATP and inhibited myocyte oncosis. The increase in myocardial ATP and relocalization of dystrophin to the sarcolemma mediated by IPC was inhibited by treatment with DNP or oligomycin during reperfusion. In vitro experiments demonstrated that mitochondria isolated from the ischemic IPC heart increased ATP generation and facilitated relocalization of dystrophin from the insoluble to the soluble fractions in a manner sensitive to DNP and oligomycin. CONCLUSIONS: These results suggest that enhanced relocalization of dystrophin to the sarcolemma during reperfusion may be a mechanistic link between IPC-mediated improvement of mitochondrial function and its protection against oncosis during the early phase of reperfusion. |
| | |
Authors:
|
Shiori Kyoi; Hajime Otani; Ayako Hamano; Seiji Matsuhisa; Yuzo Akita; Hiroyoshi Fujiwara; Reiji Hattori; Hiroji Imamura; Hiroshi Kamihata; Toshiji Iwasaka |
Related Documents
:
|
3113043 - Simulation of fly-waves to assess the ability of diflubenzuron to protect sheep against... 19648253 - Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemi... 19711083 - Volumetric quantification of myocardial perfusion using analysis of multi-detector comp... |
Publication Detail:
|
Type: Journal Article Date: 2006-02-08 |
Journal Detail:
|
Title: Cardiovascular research Volume: 70 ISSN: 0008-6363 ISO Abbreviation: Cardiovasc. Res. Publication Date: 2006 May |
Date Detail:
|
Created Date: 2006-04-25 Completed Date: 2006-09-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0077427 Medline TA: Cardiovasc Res Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 354-63 Citation Subset: IM |
Affiliation:
|
Cardiovascular Center, Kansai Medical University, Moriguchi City, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
2,4-Dinitrophenol
/
pharmacology Adenosine Triphosphate / analysis, metabolism Animals Cell Membrane Permeability Creatine Kinase / metabolism Dystrophin / analysis, metabolism* Enzyme Inhibitors / pharmacology Ischemic Preconditioning, Myocardial* Male Microscopy, Fluorescence Myocardial Reperfusion* Myocytes, Cardiac / drug effects, metabolism* Oligomycins / pharmacology Organometallic Compounds / pharmacology Rats Rats, Sprague-Dawley Sarcolemma / chemistry, metabolism Uncoupling Agents / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Dystrophin; 0/Enzyme Inhibitors; 0/Oligomycins; 0/Organometallic Compounds; 0/Uncoupling Agents; 0/tetramethyl rhodamine ethyl ester; 51-28-5/2,4-Dinitrophenol; 56-65-5/Adenosine Triphosphate; EC 2.7.3.2/Creatine Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prion protein mRNA expression in Xenopus laevis: no induction during melanotrope cell activation.
Next Document: Integrin signalling: the tug-of-war in heart hypertrophy.